Eli Lilly Acquires 4E Therapeutics to Expand Chronic Pain Treatment Portfolio

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised 4E Therapeutics. 4E Therapeutics, an Austin-based neuroscience company, has announced its acquisition by Eli Lilly and Company (NYSE: LLY)….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here